Royal Bank of Canada’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-600
Closed -$87K 7031
2024
Q4
$87K Buy
+600
New +$93K ﹤0.01% 5413
2024
Q1
Sell
-199,800
Closed -$31.3M 7291
2023
Q4
$31.3M Hold
199,800
0.01% 1013
2023
Q3
$31.1M Sell
199,800
-200
-0.1% -$33K 0.01% 927
2023
Q2
$33.1M Buy
200,000
+24,000
+14% +$3.87M 0.01% 896
2023
Q1
$27.3M Sell
176,000
-49,000
-22% -$7.91M 0.01% 947
2022
Q4
$39.7M Buy
225,000
+175,000
+350% +$30.2M 0.01% 768
2022
Q3
$8.17M Buy
+50,000
New +$8.46M ﹤0.01% 1694
2021
Q4
Sell
-445,000
Closed -$71.9M 7784
2021
Q3
$71.9M Buy
+445,000
New +$75.9M 0.02% 609
2021
Q2
Sell
-100,000
Closed -$16.4M 7579
2021
Q1
$16.4M Buy
100,000
+79,500
+388% +$12.9M ﹤0.01% 1410
2020
Q4
$3.23M Buy
20,500
+500
+3% +$73.8K ﹤0.01% 2510
2020
Q3
$2.98M Sell
20,000
-27,000
-57% -$4M ﹤0.01% 2371
2020
Q2
$6.61M Sell
47,000
-88,400
-65% -$12.9M ﹤0.01% 1750
2020
Q1
$17.8M Buy
135,400
+45,400
+50% +$6.44M 0.01% 973
2019
Q4
$13.1M Sell
90,000
-409,300
-82% -$55.5M ﹤0.01% 1437
2019
Q3
$64.6M Buy
499,300
+454,000
+1,002% +$59.8M 0.03% 503
2019
Q2
$6.31M Sell
45,300
-160,100
-78% -$22.2M ﹤0.01% 1903
2019
Q1
$28.7M Sell
205,400
-151,000
-42% -$20.2M 0.01% 839
2018
Q4
$46M Buy
356,400
+158,900
+80% +$22.2M 0.02% 551
2018
Q3
$27.3M Sell
197,500
-150,000
-43% -$19.9M 0.01% 932
2018
Q2
$42.2M Buy
347,500
+274,600
+377% +$34.3M 0.02% 642
2018
Q1
$9.34M Buy
72,900
+22,800
+46% +$3.08M ﹤0.01% 1584
2017
Q4
$7M Hold
50,100
﹤0.01% 1840
2017
Q3
$6.51M Sell
50,100
-5,000
-9% -$663K ﹤0.01% 1815
2017
Q2
$7.29M Sell
55,100
-42,500
-44% -$5.42M ﹤0.01% 1715
2017
Q1
$12.2M Sell
97,600
-610,600
-86% -$72.9M 0.01% 1370
2016
Q4
$81.6M Sell
708,200
-210,400
-23% -$24.3M 0.04% 348
2016
Q3
$109M Buy
918,600
+285,300
+45% +$34.6M 0.06% 262
2016
Q2
$76.8M Buy
633,300
+218,000
+52% +$24.8M 0.05% 327
2016
Q1
$44.9M Buy
415,300
+7,200
+2% +$745K 0.03% 496
2015
Q4
$41.9M Sell
408,100
-141,900
-26% -$14.3M 0.03% 523
2015
Q3
$51.3M Buy
550,000
+360,000
+189% +$34.8M 0.04% 348
2015
Q2
$18.5M Buy
190,000
+43,500
+30% +$4.36M 0.01% 865
2015
Q1
$14.7M Sell
146,500
-219,000
-60% -$22.3M 0.01% 997
2014
Q4
$38.2M Buy
365,500
+316,900
+652% +$33.4M 0.02% 529
2014
Q3
$5.18M Buy
48,600
+20,000
+70% +$2.07M ﹤0.01% 1626
2014
Q2
$2.99M Hold
28,600
﹤0.01% 2007
2014
Q1
$2.81M Sell
28,600
-492,300
-95% -$45.6M ﹤0.01% 2008
2013
Q4
$47.7M Buy
520,900
+35,500
+7% +$3.27M 0.03% 389
2013
Q3
$42.1M Buy
485,400
+50,000
+11% +$4.49M 0.03% 410
2013
Q2
$37.4M Buy
+435,400
New +$36.9M 0.03% 431

Other funds holding JNJ

Royal Bank of Canada's JNJ Position: Q1 2026 in Review

Royal Bank of Canada reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q1 2026, selling an estimated $210M and leaving 13,387,402 shares worth $3.27B. The position accounts for 0.57% of the portfolio, ranked #33.

Royal Bank of Canada first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,633 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Royal Bank of Canada held 13,387,402 shares of Johnson & Johnson worth $3.27B as of Q1 2026.
  • Royal Bank of Canada sold 900,159 Johnson & Johnson shares in Q1 2026, an estimated $210M.
  • Johnson & Johnson made up 0.57% of Royal Bank of Canada's portfolio in Q1 2026, its #33 holding.
  • Royal Bank of Canada first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.